Pete Shuster's statement regarding an expectation of profits by the end of Q1 2015 suggests that VODG is anticipating a relatively large increase in quarterly revenues over the course of the next couple/few quarters.
Based on the Q3 pre-announcement in the above press release, VODG continues to experience sequential revenue growth in fiscal 2014.....
Q1: $26K Q2: $35K Q3: $47K
I'm guessing that VODG's operating expenses probably will not show any significant decrease during the next few quarters. So assuming VODG achieves profitability as a result of operational activity (and not as a result of debt forgiveness), Shuster's statement probably implies that VODG expects its quarterly revenue level will double/triple ($100-200K) by the first quarter or two of fiscal 2015.
Also somewhat noteworthy in this press release is the paragraph devoted to MSC-Gro Media and its potential for use in human clinical applications. It has been mentioned in previous SEC filings, but to the best of my recall this may have been the first time it has been a prominent part of any press release. So that paragraph and Musick also mentioning it in his "commentary" section of the press release probably suggests VODG may be getting closer to making a regulatory application (510K), or at the very least strengthening its efforts in that area......
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.